782 results on '"Debruyne, Frans"'
Search Results
2. Editorial for the Abstracts of the 21st Meeting of the Association of Academic European Urologists [European Urology Open Science 2024;60 (Suppl 1):S1-39]
3. Testosterone suppression combined with high dose estrogen as potential treatment of SARS-CoV-2. A mini review
4. Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study
5. A Prospective Multicenter Comparison Study of Risk-adapted Ultrasound-directed and Magnetic Resonance Imaging–directed Diagnostic Pathways for Suspected Prostate Cancer in Biopsy-naïve Men
6. The Loss of Estradiol by Androgen Deprivation in Prostate Cancer Patients Shows the Importance of Estrogens in Males.
7. Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi)
8. Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study/SPCG11
9. Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone–Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist
10. Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormonee-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist.
11. Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations
12. Editorial for the Abstracts of the 20th Meeting of the Association of Academic European Urologists [European Urology Open Science 2023;48(Suppl 1):S1–48]
13. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME)
14. Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial
15. Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review
16. Remote surgical education using synthetic models combined with an augmented reality headset
17. Editorial for the Abstracts of the 19th Meeting of the Association of Academic European Urologists (AAEU) (European Urology Open Science 42(Suppl. 1))
18. Discussion, Conclusions and Future Prospects
19. Technical Aspects of MRI Specific Relevant to Patients with Carcinoma of the Urinary Bladder
20. General Principles of MRI
21. Staging of Carcinoma of the Urinary Bladder on the Basis of MRI Results
22. Normal Mr Images: Correlation with Kwown Anatomic Proportions
23. Introduction
24. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men
25. Role of Testosterone in Managing Advanced Prostate Cancer
26. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance–Ultrasound Fusion Guided Biopsy Using Local Anesthesia
27. Time to Onset of Action of Vardenafil: A Retrospective Analysis of the Pivotal Trials for the Orodispersible and Film‐Coated Tablet Formulations
28. Improvement in Sexual Quality of Life of the Female Partner Following Vardenafil Treatment of Men with Erectile Dysfunction: A Randomized, Double‐Blind, Placebo‐Controlled Study
29. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy
30. Summary
31. The POTENT I Randomized Trial: Efficacy and Safety of an Orodispersible Vardenafil Formulation for the Treatment of Erectile Dysfunction
32. Dose-ranging Study of the Luteinizing Hormone-releasing Hormone Receptor Antagonist Cetrorelix Pamoate in the Treatment of Patients With Symptomatic Benign Prostatic Hyperplasia
33. Clinical implementation of pre‐biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancer
34. Reply to Bexultan Kazybay and Yingqiu Xie’s Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024
35. The post-finasteride syndrome: possible etiological mechanisms and symptoms
36. Placebo-Controlled Dose-Ranging Phase 2 Study of Subcutaneously Administered LHRH Antagonist Cetrorelix in Patients with Symptomatic Benign Prostatic Hyperplasia
37. Clinical implementation of pre‐biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancer.
38. Potential occupational health problems for dentists in Flanders, Belgium
39. Bladder Cancer: Management and Future Directions
40. The Continuing Role of PSA in the Detection and Management of Prostate Cancer
41. Innovators in urology
42. Implant-Driven Tibial Nerve Stimulation in the Treatment of Refractory Overactive Bladder Syndrome: 12-Month Follow-up
43. Androgens and Benign Prostatic Hyperplasia
44. Hormone Therapy: Improving Therapy Decisions and Monitoring
45. Future of European Urology
46. Transurethral microwave thermotherapy in benign prostatic hyperplasia
47. Speaking fundamental frequency in monozygotic and dizygotic twins
48. Transient tenascin enhancement is an early event after androgen ablation in rat prostate
49. Selective detrusor activation by sacral ventral nerve-root stimulation: results of intraoperative testing in humans during implantation of a Finetech-Brindley system
50. The role of nocturia in the quality of life of men with lower urinary tract symptoms
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.